Join the community - networking, discussion and more. Open to all.
More informationCould you write an interesting article for the RQA community?
More informationIssue 170, June 2023
Meeting Highlights
Meeting Highlights
Building upon the experience of the submission of real-world evidence for regulatory purpose and the conclusions of previous activities around data standardisation, metadata, data quality and DARWIN EU®.
A roundup of FDA news
This guidance provides information to sponsors and nonclinical laboratories regarding the use and management of whole slide images used during histopathology assessment and/or pathology peer review performed for good laboratory practice (GLP)-compliant nonclinical toxicology studies using non-human specimens.
The government intends to introduce regulations in future that will implement a substantial reform of the current regulatory framework for medical devices in the UK.
Mr David Crundwell joined the Commission on Human Medicines on 12 June 2023 as a lay representative.
Countries of the World Health Organization (WHO) have moved forward negotiations on a global accord on pandemic prevention, preparedness and response, with a view to presenting a draft accord to the World Health Assembly in May 2024.
The Medicines and Healthcare products Regulatory Agency (MHRA) has launched new guidance to highlight the latest safety advice on the steps to take during anaphylaxis. This new guidance includes an easy step-by-step guide on what to do in an emergency and provides updated advice on body positioning.